Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.17 is 31% above its 5-year average of 0.13, near the high end of its 5-year range (0.07–0.19).
As of the fiscal period ended Tuesday, June 30, 2026. 3.63% below its 12-month average of 0.18.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.17.
DEBT TO EQUITY RATIO
0.17
DEBT TO EQUITY RATIO AVG TTM
0.18
DEBT TO EQUITY RATIO AVG 3Y
0.15
DEBT TO EQUITY RATIO AVG 5Y
0.13
DEBT TO EQUITY RATIO AVG 10Y
0.09
DEBT TO EQUITY RATIO AVG 15Y
0.08
DEBT TO EQUITY RATIO AVG 20Y
0.08
CURRENT VS TTM AVG
-3.63%
CURRENT VS 3Y AVG
+10.83%
CURRENT VS 5Y AVG
+31.01%
CURRENT VS 10Y AVG
+87.02%
CURRENT VS 15Y AVG
+119.64%
CURRENT VS 20Y AVG
+102.87%
SECTOR MEDIAN · HEALTHCARE
0.15
median of 412 covered companies
CURRENT VS SECTOR MEDIAN
+17.13%
vs the sector median at left
Anika Therapeutics, Inc.
Market Cap
$264.05M
Debt to Equity Ratio
0.17
TTM Avg
0.18
3Y Avg
0.15
5Y Avg
0.13
Market Cap
$264.07M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$264.10M
Debt to Equity Ratio
0.13
TTM Avg
0.07
3Y Avg
0.16
5Y Avg
0.51
Market Cap
$267.99M
Debt to Equity Ratio
0.15
TTM Avg
0.30
3Y Avg
0.26
5Y Avg
0.22
Market Cap
$259.30M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
1.47
5Y Avg
1.27
Market Cap
$276.26M
Debt to Equity Ratio
0.04
TTM Avg
0.11
3Y Avg
0.22
5Y Avg
0.26
Market Cap
$251.64M
Debt to Equity Ratio
N/A
TTM Avg
0.09
3Y Avg
0.09
5Y Avg
1.23
Market Cap
$248.21M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | $264.05M | 0.17 | 0.18 | 0.15 | 0.13 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.07M | 0.00 | 0.00 | 0.02 | 0.02 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $264.10M | 0.13 | 0.07 | 0.16 | 0.51 |
| Century Therapeutics, Inc. (IPSC)vs › | $267.99M | 0.15 | 0.30 | 0.26 | 0.22 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 0.01 | 0.00 | 1.47 | 1.27 |
| AC Immune S.A. (ACIU)vs › | $275.81M | 0.12 | 0.08 | 0.05 | 0.04 |
| Aurora Cannabis Inc. (ACB)vs › | $276.26M | 0.04 | 0.11 | 0.22 | 0.26 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | N/A | 0.09 | 0.09 | 1.23 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 0.00 | 0.00 | 0.00 | 0.00 |
| InflaRx N.V. (IFRX)vs › | $247.45M | 0.01 | 0.01 | 0.01 | 0.01 |
Debt/Equity
0.17
Current Ratio
4.48
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.17 |
| 2026-03-31 | 0.19 |
| 2025-12-31 | 0.18 |
| 2025-09-30 | 0.17 |
| 2025-06-30 | 0.17 |
| 2025-03-31 | 0.17 |
| 2024-12-31 | 0.17 |
| 2024-09-30 | 0.15 |
| 2024-06-30 | 0.13 |
| 2024-03-31 | 0.14 |
| 2023-12-31 | 0.13 |
| 2023-09-30 | 0.11 |
| 2023-06-30 | 0.11 |
| 2023-03-31 | 0.11 |
| 2022-12-31 | 0.11 |
| 2022-09-30 | 0.11 |
| 2022-06-30 | 0.11 |
| 2022-03-31 | 0.07 |
| 2021-12-31 | 0.07 |
| 2021-09-30 | 0.07 |
| 2021-06-30 | 0.08 |
| 2021-03-31 | 0.08 |
| 2020-12-31 | 0.08 |
| 2020-09-30 | 0.17 |
| 2020-06-30 | 0.25 |
| 2020-03-31 | 0.08 |
| 2019-12-31 | 0.08 |
| 2019-09-30 | 0.08 |
| 2019-06-30 | 0.09 |
| 2019-03-31 | 0.09 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.07 |
| 2013-06-30 | 0.07 |
| 2013-03-31 | 0.08 |
| 2012-12-31 | 0.09 |
| 2012-09-30 | 0.10 |
| 2012-06-30 | 0.10 |
| 2012-03-31 | 0.11 |
| 2011-12-31 | 0.12 |
| 2011-09-30 | 0.12 |
| 2011-06-30 | 0.13 |
| 2011-03-31 | 0.14 |
| 2010-12-31 | 0.15 |
| 2010-09-30 | 0.16 |
| 2010-06-30 | 0.17 |
| 2010-03-31 | 0.17 |
| 2009-12-31 | 0.18 |
| 2009-09-30 | 0.23 |
| 2009-06-30 | 0.24 |
| 2009-03-31 | 0.25 |
| 2008-12-31 | 0.03 |
| 2008-09-30 | 0.13 |
| 2008-06-30 | 0.14 |
| 2008-03-31 | 0.07 |
| 2007-12-31 | 0.00 |
| 2007-09-30 | 0.00 |
| 2007-06-30 | 0.00 |
| 2007-03-31 | 0.00 |
| 2006-12-31 | 0.00 |
| 2006-09-30 | 0.00 |
| 2006-06-30 | 0.00 |
| 2006-03-31 | 0.00 |
| 2005-12-31 | 0.00 |
| 2005-09-30 | 0.00 |
| 2005-06-30 | 0.00 |
| 2005-03-31 | 0.00 |
| 2004-12-31 | 0.00 |
| 2004-09-30 | 0.00 |
| 2004-06-30 | 0.00 |
| 2004-03-31 | 0.00 |
| 2003-12-31 | 0.00 |
| 2003-09-30 | 0.00 |
| 2003-06-30 | 0.00 |
| 2003-03-31 | 0.00 |
| 2002-12-31 | 0.00 |
| 2002-09-30 | 0.00 |
